Characteristics of Mediastinal Lymph Node With False Positive FDG PET/CT Results in Lung Cancer Staging : Relation With TB and Latent TB Infection
N/A
20 Years
75 Years
20 Years
75 Years
Not Enrolling
Both
Lung Cancer
Both
Lung Cancer
Trial Information
Characteristics of Mediastinal Lymph Node With False Positive FDG PET/CT Results in Lung Cancer Staging : Relation With TB and Latent TB Infection
Inclusion Criteria:
- age 20-75, men and women
- person who performed PET/CT and surgical biopsy of mediastinal lymph node for
diagnosis of primary lung cancer of metastatic lung cancer
Exclusion Criteria:
- age < 20
- person who don't agree with enrollment
- illiterate
- person who is diagnosed as active tuberculosis now
- person who has history of hypersensitivity on PPD (tuberculin purified protein
derivative)
- pregnant woman
- person who is treated as active tuberculosis
Type of Study:
Observational
Study Design:
Observational Model: Case-Crossover, Time Perspective: Prospective
Outcome Measure:
false positive rate of Mediastinal Lymph Node
Outcome Time Frame:
3months
Safety Issue:
No
Authority:
South Korea: Korea Food and Drug Administration (KFDA)
Study ID:
4-2011-0196
NCT ID:
NCT01376856
Start Date:
June 2011
Completion Date:
November 2011
Related Keywords:
- Lung Cancer
- mediastinal lymph node with false positive FDG PET/CT results in lung cancer staging
- Lung Neoplasms
Name | Location |
|---|
